In these studies, the degree of tau and amyloid beta (Aβ) pathology in the main target regions of the EC has been associated with the degree and course of cognitive impairment in these patients, with the association being stronger in the case of tau (see also Nelson et al., 2012). This evidence concerns the gene MAPT and Cognitive impairment.